First Citizens BancShares Inc vs Philip Morris International Inc. — how do they compare? First Citizens BancShares Inc trades at $2,124.52 (market cap $23.76B), while Philip Morris International Inc. trades at $187.42 (market cap $281.91B). The key difference: Philip Morris International Inc. is far larger — about 11.9× First Citizens BancShares Inc's market cap, and Philip Morris International Inc. pays the higher dividend (3.25%). Which is the better fit depends on your goals.
| FCNCA | PM | |
|---|---|---|
Market Cap | $23.76B | $281.91B |
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $2.20K | $191.86 |
52-Week Low | $1.64K | $144.33 |
Dividend Yield | 0.41% | 3.25% |
Enterprise Value | — | $328.41B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $175.95, down 2.35% amid a bearish technical signal and recent profit forecast revision. The company reported strong Q1 2026 EPS of $1.96, beating estimates, but faces headwinds from a $500 million impairment charge and margin pressures. Revenue growth remains steady, with 2025 revenue at $40.65 billion and net income margin of 26.74%. Analyst consensus is bullish with a $194 price target, though technical indicators show resistance near $179.
The stock presents a mixed outlook: solid fundamentals and high analyst buy ratings support upside potential, but near-term risks include cost pressures, currency volatility, and illicit market growth. Long-term investors may find value in the dividend and brand strength, while caution is warranted due to regulatory and macroeconomic challenges.
Trailing returns across standard periods
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →